Document Detail


Effects of presentation and electrocardiogram on time to treatment of hyperkalemia.
MedLine Citation:
PMID:  18304054     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: To assess the time to treatment for emergency department (ED) patients with critical hyperkalemia and to determine whether the timing of treatment was associated with clinical characteristics or electrocardiographic abnormalities. METHODS: The authors performed a retrospective chart review of ED patients with the laboratory diagnosis of hyperkalemia (potassium level > 6.0 mmol/L). Patients presenting in cardiac arrest or who were referred for hyperkalemia or dialysis were excluded. Patient charts were reviewed to find whether patients received specific treatment for hyperkalemia and, if so, what clinical attributes were associated with the time to initiation of treatment. RESULTS: Of 175 ED visits that occurred over a 1-year time period, 168 (96%) received specific treatment for hyperkalemia. The median time from triage to initiation of treatment was 117 minutes (interquartile range [IQR] = 59 to 196 minutes). The 7 cases in which hyperkalemia was not treated include 4 cases in which the patient was discharged home, with a missed diagnosis of hyperkalemia. Despite initiation of specific therapy for hyperkalemia in 168 cases, 2 patients died of cardiac arrhythmias. Among the patients who received treatment, 15% had a documented systolic blood pressure (sBP) < 90 mmHg, and 30% of treated patients were admitted to intensive care units. The median potassium value was 6.5 mmol/L (IQR = 6.3 to 7.1 mmol/L). The predominant complaints were dyspnea (20%) and weakness (19%). Thirty-six percent of patients were taking angiotensin-converting enzyme (ACE) inhibitors. Initial electrocardiograms (ECGs) were abnormal in 83% of patient visits, including 24% of ECGs with nonspecific ST abnormalities. Findings of peaked T-wave morphology (34%), first-degree atrioventricular block (17%), and interventricular conduction delay (12%) did not lead to early treatment. Vital sign abnormalities, including hypotension (sBP < 90 mmHg), were not associated with early treatment. The chief complaint of "unresponsive" was most likely to lead to early treatment; treatment delays occurred in patients not transported by ambulance, those with a chief complaint of syncope and those with a history of hypertension. CONCLUSIONS: Recognition of patients with severe hyperkalemia is challenging, and the initiation of appropriate therapy for this disorder is frequently delayed.
Authors:
Kalev Freeman; James A Feldman; Patricia Mitchell; Jacqueline Donovan; K Sophia Dyer; Laura Eliseo; Laura Forsberg White; Elizabeth S Temin
Related Documents :
20616664 - Cardiomyopathy in congenital and acquired generalized lipodystrophy: a clinical assessm...
17395674 - Qrs and qtc interval prolongation in the prediction of long-term mortality of patients ...
23421484 - Baseline airway inflammation may be a determinant of the response to ozone exposure in ...
1892084 - Adrenergic hypersensitivity after beta-blocker withdrawal in hypertrophic cardiomyopathy.
24738974 - Infectious lymphadenitis in patients with chronic lymphocytic leukemia/small lymphocyti...
9924214 - Increased erythrocyte aggregation as an indicator for an aggressive clinical course in ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Academic emergency medicine : official journal of the Society for Academic Emergency Medicine     Volume:  15     ISSN:  1553-2712     ISO Abbreviation:  Acad Emerg Med     Publication Date:  2008 Mar 
Date Detail:
Created Date:  2008-02-28     Completed Date:  2008-07-21     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9418450     Medline TA:  Acad Emerg Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  239-49     Citation Subset:  IM    
Affiliation:
Department of Surgery, University of Vermont College of Medicine, Burlington, VT, USA. kalev.freeman@uvm.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Chi-Square Distribution
Cohort Studies
Electrocardiography*
Emergency Service, Hospital / statistics & numerical data*
Female
Heart Arrest / diagnosis*,  etiology
Humans
Hyperkalemia / blood,  complications,  diagnosis*,  therapy*
Male
Middle Aged
Multivariate Analysis
Observer Variation
Potassium / blood
Process Assessment (Health Care)
Retrospective Studies
Time Factors
United States
Chemical
Reg. No./Substance:
7440-09-7/Potassium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Validation set correlates of anogenital injury after sexual assault.
Next Document:  Delta 2-specific opioid receptor agonist and hibernating woodchuck plasma fraction provide ischemic ...